Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model

Abstract

The limited evidence-base of the health impact of resistant infection in UTIs limits economic studies estimating the overall burden of AMR. Such data are increasingly important and are urgently needed to support local clinical practice as well as national and global efforts to curb the spread of AMR.